Reference : Effect of Apremilast and Etanercept on Pruritus and Health-Related Quality of Life in...
Scientific congresses and symposiums : Poster
Human health sciences : Dermatology
http://hdl.handle.net/2268/199088
Effect of Apremilast and Etanercept on Pruritus and Health-Related Quality of Life in Patients With Moderate to Severe Plaque Psoriasis : Results From the LIBERATE Study
English
Green, Lawrence []
Thaçi, Diamant []
Zhang, Zuoshun []
Goncalves, Joana []
Nograles, Kristine []
NIKKELS, Arjen mailto [Centre Hospitalier Universitaire de Liège - CHU > > Service de dermatologie >]
May-2016
No
American Academy of Dermatology
MAY 2016
[en] Apremilast ; Etanercept ; pruritus ; psoriasis
[en] Psoriasis is a chronic, systemic inflammatory disease with skin maniifestations resulting from a dysregulated immune response. Itching is one of the most bothersome psoriasis symptoms for patients and important factor contributing to disease severity. Apremilast , is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor, works intracellularly within immune cells to regulate the production of inflammatory médiators associated with the pathogenesis of psoriasis by increasing cyclic adenosine monophophate (cAMP) levels. Apremilast was approved by the US Food and Drug Administration for the treatment of adult patients with patients with active psoriatic arthritis and for patients with moderate to severe plaque psoriasis. Apremilast has since been approved in multiple countries, including those in European Union,as well as Switzerland, Canada and Australia. LIBERATE (Evaluation in Placebo-Controlled Study of Oral Apremilast and Etanercept in Plaque Psoriasis; NCT01690299) is global phase 3b study evaluating the efficacity, safety, and tolerability of apremilast or etarnercept, compared with placebo, for the treatment of biologic-naive patients with moderate to severe plaque psoriasis.
http://hdl.handle.net/2268/199088

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Effect of Apremilast and Etanercept on Pruritus and Health Related Quality of Life in Patients With Moderate to Severe Plaque Psoriasis Results From the LIBERATE Study.pdfPublisher postprint582.29 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.